Annual Operating Expenses
$958.25 M
-$25.68 M-2.61%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual total operating expenses is $958.25 million, with the most recent change of -$25.68 million (-2.61%) on December 31, 2023.
- During the last 3 years, RARE annual operating expenses has risen by +$363.23 million (+61.05%).
- RARE annual operating expenses is now -2.61% below its all-time high of $983.93 million, reached on December 31, 2022.
Performance
RARE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$250.46 M
+$8.35 M+3.45%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly total operating expenses is $250.46 million, with the most recent change of +$8.35 million (+3.45%) on September 30, 2024.
- Over the past year, RARE quarterly operating expenses has increased by +$18.30 million (+7.88%).
- RARE quarterly operating expenses is now -18.45% below its all-time high of $307.14 million, reached on September 30, 2022.
Performance
RARE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RARE Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | +7.9% |
| 3 y3 years | +61.0% | +49.7% |
| 5 y5 years | +127.2% | +77.4% |
RARE Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.6% | +33.6% | -18.4% | +37.3% |
| 5 y | 5-year | -2.6% | +84.7% | -18.4% | +103.7% |
| alltime | all time | -2.6% | >+9999.0% | -18.4% | +5254.0% |
Ultragenyx Pharmaceutical Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $250.46 M(+3.5%) |
| Jun 2024 | - | $242.11 M(-5.7%) |
| Mar 2024 | - | $256.65 M(+8.1%) |
| Dec 2023 | $958.25 M(-2.6%) | $237.39 M(+2.3%) |
| Sep 2023 | - | $232.16 M(-5.8%) |
| Jun 2023 | - | $246.35 M(+1.7%) |
| Mar 2023 | - | $242.34 M(-0.5%) |
| Dec 2022 | $983.93 M(+37.2%) | $243.66 M(-20.7%) |
| Sep 2022 | - | $307.14 M(+37.9%) |
| Jun 2022 | - | $222.67 M(+5.8%) |
| Mar 2022 | - | $210.47 M(+15.4%) |
| Dec 2021 | $717.13 M(+20.5%) | $182.44 M(+9.1%) |
| Sep 2021 | - | $167.30 M(+0.4%) |
| Jun 2021 | - | $166.62 M(-17.0%) |
| Mar 2021 | - | $200.78 M(+10.2%) |
| Dec 2020 | $595.02 M(+14.7%) | $182.14 M(+40.7%) |
| Sep 2020 | - | $129.44 M(+5.3%) |
| Jun 2020 | - | $122.96 M(-23.4%) |
| Mar 2020 | - | $160.48 M(+28.4%) |
| Dec 2019 | $518.88 M(+23.0%) | $124.94 M(-11.5%) |
| Sep 2019 | - | $141.15 M(+3.9%) |
| Jun 2019 | - | $135.86 M(+16.2%) |
| Mar 2019 | - | $116.93 M(+10.2%) |
| Dec 2018 | $421.72 M | $106.09 M(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $101.14 M(-6.0%) |
| Jun 2018 | - | $107.55 M(+0.6%) |
| Mar 2018 | - | $106.94 M(+7.8%) |
| Dec 2017 | $331.55 M(+33.6%) | $99.25 M(+18.3%) |
| Sep 2017 | - | $83.91 M(+7.0%) |
| Jun 2017 | - | $78.44 M(+12.1%) |
| Mar 2017 | - | $69.95 M(-0.9%) |
| Dec 2016 | $248.14 M(+68.0%) | $70.55 M(+7.1%) |
| Sep 2016 | - | $65.89 M(+13.5%) |
| Jun 2016 | - | $58.07 M(+8.3%) |
| Mar 2016 | - | $53.62 M(-4.5%) |
| Dec 2015 | $147.74 M(+160.2%) | $56.16 M(+40.6%) |
| Sep 2015 | - | $39.94 M(+32.5%) |
| Jun 2015 | - | $30.14 M(+40.2%) |
| Mar 2015 | - | $21.50 M(+26.9%) |
| Dec 2014 | $56.78 M(+75.9%) | $16.94 M(+7.0%) |
| Sep 2014 | - | $15.84 M(+15.9%) |
| Jun 2014 | - | $13.66 M(+32.1%) |
| Mar 2014 | - | $10.34 M(+8.5%) |
| Dec 2013 | $32.28 M(+101.9%) | $9.53 M(+22.7%) |
| Sep 2013 | - | $7.76 M(-5.9%) |
| Jun 2013 | - | $8.25 M(+22.2%) |
| Mar 2013 | - | $6.75 M(+44.2%) |
| Dec 2012 | $15.98 M(+143.6%) | $4.68 M |
| Dec 2011 | $6.56 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total operating expenses?
- What is the all time high annual operating expenses for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual operating expenses year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly operating expenses year-on-year change?
What is Ultragenyx Pharmaceutical annual total operating expenses?
The current annual operating expenses of RARE is $958.25 M
What is the all time high annual operating expenses for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total operating expenses is $983.93 M
What is Ultragenyx Pharmaceutical annual operating expenses year-on-year change?
Over the past year, RARE annual total operating expenses has changed by -$25.68 M (-2.61%)
What is Ultragenyx Pharmaceutical quarterly total operating expenses?
The current quarterly operating expenses of RARE is $250.46 M
What is the all time high quarterly operating expenses for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total operating expenses is $307.14 M
What is Ultragenyx Pharmaceutical quarterly operating expenses year-on-year change?
Over the past year, RARE quarterly total operating expenses has changed by +$18.30 M (+7.88%)